about
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprintsA pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreakRoutine use of microbial whole genome sequencing in diagnostic and public health microbiologyThe role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.Read length and repeat resolution: exploring prokaryote genomes using next-generation sequencing technologies.Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiologyGenome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission settingRapid single-colony whole-genome sequencing of bacterial pathogens.Drug-resistance mechanisms and tuberculosis drugsNew methods for identifying infectious diseases.Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus.Impact of Fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824.Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak.Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreakSingle-nucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance.Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and MoxifloxacinWhole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from MyanmarWhole-genome sequencing for rapid susceptibility testing of M. tuberculosis.Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives.Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex.Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.Thr270Ile in embC (Rv3793) is not a marker for ethambutol resistance in the Mycobacterium tuberculosis complex.Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay.Comment on: characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array.dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.Consequences of whiB7 (Rv3197A) mutations in Beijing genotype isolates of the Mycobacterium tuberculosis complex.Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid.What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.[The validity of Mycobacterium tuberculosis complex species identification. Comments on the article: "Differentiation of species within the Mycobacterium tuberculosis complex by molecular techniques"].A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.Convergent evolution and topologically disruptive polymorphisms among multidrug-resistant tuberculosis in Peru.Limited evidence for need for region-specific, genotypic drug-susceptibility assays for Mycobacterium tuberculosis.Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis"'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanidWorld Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme SeriesPhylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex
P50
Q28476294-DEC26F87-C39B-49E0-864C-EC9079FAA3D8Q28709555-0B339712-D1F5-4832-9739-7126ADF7B767Q28728617-8EE86608-75D3-4F3C-97BE-C95E4CE69B0CQ30240583-5DB1B4CC-8984-4F0F-870E-4F4946E707DDQ33633992-2F539402-0627-4D53-A7FD-BDB70A43EBF4Q34290168-19DF1F3B-EFE8-4172-8ADB-D4EFFBA300E6Q34822378-676F89B0-3AEA-4A5E-8602-2FC1916FAD28Q35049375-94F5CDFB-CCBC-4C9C-8B74-0B2968152520Q35076491-5B44F34E-A693-4CA9-9F37-E12AD148FB9CQ35218108-21E2E203-296C-401A-B439-8D25C57E1E40Q35293726-C890A95B-083A-42AD-9EEA-9DD58138DDC0Q35558082-149A8AB2-97A2-4EAA-BDE9-1AD17800F6ADQ35598383-07DBC272-D7DE-43AC-8CF1-3CBEC0C41384Q36559099-B9D88AFD-4A23-48A8-93F6-734270A07AADQ37025859-E9FB3E17-11D1-4F59-9AF3-27BA35DB8977Q37051424-FF0BD863-D175-4CF9-9CA5-B4286BAC1AE7Q37203747-4095C009-0206-41F9-8DF7-E2BD9BDADCF3Q37229528-071C71CC-0296-48EB-9D23-26C671648F35Q37331576-E2E54B46-F716-4C64-B1D9-C1117BAE5868Q37720805-DD6C4D9E-324D-468C-9405-D85CA1E85369Q38798998-6A972AB8-3918-4D61-B4A3-6B1D6972B94CQ38829192-5F114F2F-01FE-4406-97FF-38E5613BBC6EQ38863350-E3D05121-643F-4F27-AB99-CEA066FB530EQ41991754-881A959A-1FDC-4BAE-84AA-119771953119Q42421215-B2EE3118-8E95-4603-BC87-5EC2922AC784Q42706352-6FA2F61C-9229-4514-91FE-F0A9F7B79DB4Q42714470-D1F0A5CC-BC08-4174-8846-B5FA4C56788CQ42737698-7AF2D607-C104-470F-B0B6-ADC0C8311CE4Q42763782-4CCF090F-345D-46B6-AF9F-C3146A4E3E53Q43110599-4262D5E1-039A-45C1-841F-509975EF05BEQ43759238-3626136C-A1F0-41D2-81EA-6B0BF4DEC651Q46319545-A1FD8704-45E4-48E6-A665-5B36E22E6BACQ46923360-08DA4D14-30C7-40D6-958E-C692705335DBQ47237569-C89956C3-3DC5-4D6A-A36C-DB8CACEEB3DAQ47251741-4C990758-3919-49EB-86E5-33938EB0164EQ49574111-2D3EB864-999F-488D-B33B-E8F263D02698Q59684798-457862FB-3728-4413-8BF1-A43BA7F12859Q62486610-D5AAB205-044D-42E6-AE09-60664F6CB9F2Q62486698-E9B238EA-7021-44F0-A7B0-27B4A9A19B58Q90115219-795CC8BB-A161-44A2-9465-F6A32A2E2044
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudio U Köser
@ast
Claudio U Köser
@en
Claudio U Köser
@es
Claudio U Köser
@nl
Claudio U Köser
@sl
type
label
Claudio U Köser
@ast
Claudio U Köser
@en
Claudio U Köser
@es
Claudio U Köser
@nl
Claudio U Köser
@sl
prefLabel
Claudio U Köser
@ast
Claudio U Köser
@en
Claudio U Köser
@es
Claudio U Köser
@nl
Claudio U Köser
@sl
P1053
I-3740-2013
P106
P21
P31
P3829
P496
0000-0002-0232-846X